Is CVS Health a Buy or Sell?

PUBLISHED Mar 15, 2026, 4:50:46 AM        SHARE

img
imgStock Graphs Value on YouTube

CVS Health used to be a market favorite. Its integrated model—retail pharmacy, pharmacy benefit management, and health insurance—once earned it a premium valuation. Investors saw scale, cash flow, and strategic positioning. But confidence cracked when medical costs surged, especially in Medicare Advantage, and execution faltered. The $5.7 billion impairment tied to Oak Street and Signify Health was a wake-up call. It signaled that capital allocation wasn’t working as planned, and once trust in management breaks, valuation multiples tend to fall fast.

Today, CVS is trying to rebuild. Full-year 2025 revenue came in at $372.8 billion, with adjusted EPS of $6.12. For 2026, management reaffirmed guidance of $7 to $7.20 in adjusted EPS and framed the year as a margin recovery phase. The focus is on healthcare benefits, especially insurance margins. But the stock is still trading around $76.32, far below its former highs. That tells us investors remain cautious. The real question isn’t whether CVS is statistically cheap—it’s whether it’s truly undervalued. If execution improves and the company earns even a conservative multiple, the upside could be meaningful.


CVS Health Financial Snapshot

Metric Value
2025 Revenue $372.8 billion
2025 Adjusted EPS $6.12
2026 EPS Guidance $7.00–$7.20
Recent Stock Price ~$76.32
Impairment Charge (2025) $5.7 billion

The risks are real. Medical cost pressure remains the biggest threat, especially in Medicare Advantage. CVS’s medical benefit ratio was 91.2% in 2025, and any misstep in underwriting or utilization forecasting could derail the recovery. The Aetna turnaround is another challenge. Rebuilding plan performance and credibility won’t be easy, and even small errors can damage margins. Drug pricing and PBM transparency are under constant scrutiny, and retail pharmacy reimbursement pressure hasn’t gone away. Filling more prescriptions doesn’t guarantee profitability if margins stay thin.

Capital allocation is also under the microscope. The Oak Street and Signify deals didn’t deliver as promised, and CVS is now closing clinics and slowing expansion. That dims the long-term growth story. Legal and regulatory risks add another layer of uncertainty. Aetna recently paid $17.7 million to settle Medicare coding allegations, reminding investors that compliance issues are always lurking. Still, none of these risks suggest CVS is collapsing. The real question is whether management can execute well enough to turn a cheap stock into a real recovery story.


CVS Health Risk Overview

Risk Area Description
Medical Cost Pressure Elevated costs in Medicare Advantage threaten margins and earnings recovery.
Aetna Turnaround Execution risk in rebuilding underwriting discipline and plan performance.
PBM & Drug Pricing Regulatory scrutiny and margin pressure in CVS Caremark.
Retail Pharmacy Margins Reimbursement pressure despite higher prescription volumes.
Capital Allocation Impairment charges and clinic closures reduce confidence in growth strategy.
Legal & Regulatory Medicare compliance issues highlight ongoing risk exposure.

Despite the challenges, CVS has opportunities. Insurance margin recovery is the biggest near-term lever. If pricing and utilization trends improve, earnings could rebound faster than expected. Pharmacy momentum is also helping. Higher prescription volumes and customer file acquisitions from Rite Aid support traffic and revenue. Even in a pressured reimbursement environment, stronger script volume can improve operating leverage. Cost discipline is another positive. CVS is focusing on simplification and sharper execution, and even modest efficiency gains can boost margins and free cash flow.

Longer term, the integrated model still holds promise. CVS has the pieces—insurance, PBM, pharmacy, primary care, and home-based health. If it can connect these assets more effectively and manage care at lower cost, it could build a durable competitive edge. Management is guiding for mid-teens EPS CAGR over the next three years. If that plays out, today’s valuation could look far too low in hindsight. Stronger cash flow would also give CVS more flexibility for debt reduction, dividend support, and buybacks.


CVS Health Opportunity Highlights

Opportunity Area Description
Insurance Margin Recovery Improved pricing and utilization trends could accelerate earnings rebound.
Pharmacy Momentum Higher script volume and Rite Aid acquisitions support traffic and revenue.
Cost Discipline Operational efficiency gains could lift margins and free cash flow.
Integrated Model Connecting assets could create a stronger healthcare platform.
Long-Term EPS Growth Mid-teens EPS CAGR guidance offers rerating potential.

Wall Street seems to agree. CVS currently has six strong buy ratings, 17 buy ratings, and five hold ratings. There are no sell ratings. That’s telling. Even cautious analysts aren’t betting against the stock—they’re just waiting for proof. Sentiment isn’t euphoric, but it’s clearly bullish. If CVS can stabilize insurance margins, improve execution, and rebuild credibility, the stock has room to rerate higher.

Verdict: CVS Health is a HOLD. The upside is real, but execution must improve before the market rewards it with a higher multiple. Investors should watch for margin recovery and disciplined capital allocation before upgrading their conviction.

https://youtu.be/pS-mouXdpOw?si=c9X32qwiDgur-2ul

Read More

▌ The Top Healthcare stocks



Sound investments
don't happen alone

Find your crew, build teams, compete in VS MODE, and identify investment trends in our evergrowing investment ecosystem. You aren't on an island anymore, and our community is here to help you make informed decisions in a complex world.

More Reads
Yum Brands: Premium Valuation, Portfolio Tension, and the 2026 Investment Setup
Image

Yum Brands has always lived in a unique corner of the restaurant universe. When the company is firing on all cylinders, the market rewards it with a premium valuation. That premium historically came from two pillars: consistent global unit growth through franchising and strong same‑store sales driven by brand momentum at Taco Bell and KFC.

How to Evaluate Restaurant Stocks
Image

Restaurants operate in a fast‑moving industry shaped by consumer habits, economic cycles, and operational efficiency. This guide breaks down the key factors investors use to judge whether a restaurant stock is worth owning.

Behavioral Economics: Why Consumers Choose Certain Restaurants
Image

Understanding why consumers choose certain restaurants goes beyond the menu, price, or location. Behavioral economics offers valuable insights into the psychological factors that drive customer decisions in the dining industry. Concepts like brand loyalty, habit loops, perceived value, and consumer psychology play a key role in shaping restaurant revenue and its resilience in competitive markets.

Beverage Mix and Its Outsized Impact on Restaurant Profitability
Image

In the restaurant industry, beverage sales often play a surprisingly large role in overall profitability. Drinks, from soft beverages to alcoholic options, tend to have higher profit margins than food items. Changes in beverage mix—the proportion of different drinks sold—can significantly affect earnings. This article explores why beverages command high margins, how shifts in the beverage mix influence restaurant profits, and which chains excel at leveraging beverage strategy to boost their bottom line.

ESG Factors in Restaurant Stocks
Image

Environmental, Social, and Governance (ESG) factors are increasingly influencing investment decisions across industries, including the restaurant sector. As consumers and investors become more conscious about sustainability and corporate responsibility, restaurant companies are being held to higher standards. This article explores key ESG factors such as sustainability, ethical sourcing, waste reduction, and energy use. It also examines how ESG scores impact institutional investment in restaurant stocks.

Unit Expansion Strategy: How Restaurants Scale Profitably
Image

Growing a restaurant chain is a key way to increase revenue and profits. But expanding too quickly or without strategy can backfire. A smart unit expansion strategy is critical for scaling profitably. This article explores important concepts like new-store return on investment (ROI), cannibalization risk, saturation curves, and why some chains scale better than others. Understanding these factors helps investors and restaurant operators navigate growth with confidence.

Menu Pricing Strategy and Its Impact on Restaurant Stock Margins
Image

In the restaurant industry, pricing is more than just setting a number on a menu. It is a strategic tool that can significantly influence profitability and stock performance. Understanding how menu pricing affects restaurant stock margins requires grasping concepts like price elasticity, menu engineering, shrinkflation, and pricing power. This article explains these ideas and explores their role in earnings per share (EPS) stability for restaurant companies.

How Technology Adoption Is Transforming Restaurant Profitability
Image

The restaurant industry has always been competitive, with tight profit margins and high operating costs. In recent years, technology adoption has become a powerful driver of change, transforming how restaurants operate and boosting their profitability. From point-of-sale (POS) systems to automation, artificial intelligence (AI) ordering, robotics, and loyalty apps, tech innovations are reshaping the way restaurants serve customers and manage costs.

The Supply Chain Behind Restaurant Stocks
Image

Investing in restaurant stocks means more than just betting on tasty food and popular brands. The supply chain behind these businesses plays a crucial role in their success. Understanding how food procurement, commodity exposure, logistics, and vendor concentration risk affect restaurant companies can help investors make smarter decisions. This article explores these factors and shows how disruptions in the supply chain ripple into earnings.

Why Restaurant Failure Rates Matter for Investors
Image

Investing in the restaurant industry can be rewarding but also risky. Understanding why restaurant failure rates matter for investors is key to making smart decisions. This article breaks down unit-level economics, average failure rates by segment, and how closures affect comparable sales, cash flow, and investor risk.

How Restaurant Business Models Drive Stock Performance
Image

When most people think about restaurant stocks, they picture sizzling burgers and packed dining rooms. But the real story behind a restaurant company's stock performance has less to do with the food and more to do with the business model underneath. How a company owns, operates, and scales its restaurants shapes everything from profit margins to how the stock holds up during a recession.

Is McDonald’s Stock Worth Buying at Today’s Price?
Image

McDonald’s is one of the most recognizable fast‑food brands on the planet. Almost everyone knows the golden arches, and the company has a long history of returning large portions of its free cash flow back to shareholders through dividends and share buybacks.

Is Chipotle Stock Worth Buying at Today’s Price?
Image

Chipotle has become one of the most recognizable fast‑casual restaurants in America, and for good reason. The brand is beloved, the burritos are massive, and the business has built a reputation for strong financial performance.

Is McDonald’s Stock a Buy for 2026? A Deep Dive Into Growth, Tech, and Valuation
Image

McDonald’s stock has quietly delivered a solid run in 2025. Shares are up more than 7% year‑to‑date, and when you add in the dividends, investors have enjoyed a strong return for the relatively low risk that comes with owning a global giant like McDonald’s.

Chipotle Stock: A Deep Dive Into Growth, Margins, and Whether It Still Belongs in Your Portfolio
Image

Chipotle is a giant in the restaurant industry, a brand that practically defines the fast‑casual category. But the real question investors are wrestling with right now is simple: **Is Chipotle a buy today or a problem waiting to happen?**

Monster Beverage Stock Analysis: Can It Still Win the Energy Drink War?
Image

Monster Beverage used to be *the* dominant force in energy drinks. But with Celsius exploding in popularity, investors are asking the same question: **Is Monster Beverage a buy right now?** Let’s walk through the numbers, the story, and the reality

Is McDonald’s Stock a Buy Right Now? A Full Breakdown for Long‑Term Investors
Image

McDonald’s is one of the most recognizable restaurant companies on the planet, but the real question is simple: **is the stock worth buying today**?

The Battle of the Steak House Stocks!
Image

Steakhouse chains have become a major part of the American dining scene. They offer comfort, tradition, and a sense of celebration. Investors have taken notice. A handful of publicly traded companies now dominate the steakhouse space, each with its own strategy and loyal customer base.

The Top Sit-Down Restaurants
Image

Sit‑down restaurant stocks give investors a window into a part of the food industry that depends on service, atmosphere, and customer loyalty. These companies operate full‑service restaurants where guests are seated, served by staff, and often stay longer than they would at fast‑food chains.

The Top Fast Food Stocks Rated by You!
Image

Here are all the fast food stocks, rated by our investment community! Vote for your favorite fast food joint.